Ratio Revelations: CVS Health Corp (CVS)’s Financial Metrics in the Spotlight

For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

CVS Health Corp (NYSE: CVS) closed the day trading at $60.34 down -5.23% from the previous closing price of $63.67. In other words, the price has decreased by -$5.23 from its previous closing price. On the day, 42.18 million shares were traded. CVS stock price reached its highest trading level at $60.4599 during the session, while it also had its lowest trading level at $57.495.

Ratios:

For a better understanding of CVS, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 4.65 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 14.40. For the most recent quarter (mrq), Quick Ratio is recorded 0.66 and its Current Ratio is at 0.86. In the meantime, Its Debt-to-Equity ratio is 1.12 whereas as Long-Term Debt/Eq ratio is at 1.04.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Barclays on October 10, 2024, Upgraded its rating to Overweight and sets its target price to $82 from $63 previously.

On October 04, 2024, TD Cowen Upgraded its rating to Buy which previously was Hold and also upped its target price recommendation from $59 to $85.

On May 30, 2024, Robert W. Baird started tracking the stock assigning a Neutral rating and target price of $61.Robert W. Baird initiated its Neutral rating on May 30, 2024, with a $61 target price.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on May 02 ’24 when LUDWIG EDWARD J bought 1,000 shares for $53.88 per share. The transaction valued at 53,879 led to the insider holds 21,630 shares of the business.

Mahoney Michael F bought 9,181 shares of CVS for $500,294 on May 02 ’24. The Director now owns 9,356 shares after completing the transaction at $54.49 per share. On Feb 16 ’24, another insider, Shah Prem S, who serves as the EVP and Pres-Pharm, Consumer W of the company, sold 29,473 shares for $76.95 each. As a result, the insider received 2,267,947 and left with 39,765 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CVS now has a Market Capitalization of 75906514944 and an Enterprise Value of 143647473664. As of this moment, CVS’s Price-to-Earnings (P/E) ratio for their current fiscal year is 10.74, and their Forward P/E ratio for the next fiscal year is 8.23. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.88. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.21 while its Price-to-Book (P/B) ratio in mrq is 1.01. Its current Enterprise Value per Revenue stands at 0.397 whereas that against EBITDA is 8.922.

Stock Price History:

Over the past 52 weeks, CVS has reached a high of $83.25, while it has fallen to a 52-week low of $52.77. The 50-Day Moving Average of the stock is 0.91%, while the 200-Day Moving Average is calculated to be -7.71%.

Shares Statistics:

Over the past 3-months, CVS traded about 9.66M shares per day on average, while over the past 10 days, CVS traded about 14983560 shares per day. A total of 1.29B shares are outstanding, with a floating share count of 1.26B. Insiders hold about 0.21% of the company’s shares, while institutions hold 82.72% stake in the company. Shares short for CVS as of 1727654400 were 19748955 with a Short Ratio of 2.04, compared to 1724976000 on 18495652. Therefore, it implies a Short% of Shares Outstanding of 19748955 and a Short% of Float of 1.5700001000000001.

Dividends & Splits

CVS’s forward annual dividend rate is 2.60, up from 2.54 a year ago. Against a Trailing Annual Dividend Yield of 0.0398932The stock’s 5-year Average Dividend Yield is 2.93.

Most Popular